ArticleJCI insight2025

Icosapent ethyl-induced lipoprotein remodeling and its impact on cardiovascular disease risk markers in normolipidemic individuals.

Lauri Äikäs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.